
Find Reports
Select Report Type
Reimbursement Review
Displaying 1401 - 1422 of 1422
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 1926 - 1950 of 2132
Please scroll or swipe to the right to view the full content.
Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
---|---|---|---|---|---|---|---|
Oxycodone / naloxone | Reimbursement Review | Cancelled | SR0219-000 | ||||
Self-Monitoring of Blood Glucose | Health Technology Review | ||||||
Liraglutide | Reimbursement Review | Complete | SR0217-000 | ||||
Dabigatran etexilate | Reimbursement Review | Complete | SR0214-000 | ||||
Velaglucerase alfa | Reimbursement Review | Complete | SR0215-000 | ||||
Febuxostat | Reimbursement Review | Complete | SR0213-000 | ||||
Lacosamide | Reimbursement Review | Complete | SR0212-000 | ||||
Buprenorphine transdermal patch | Reimbursement Review | Cancelled | SR0211-000 | ||||
Azelaic acid | Reimbursement Review | Complete | SR0209-000 | ||||
Denosumab | Reimbursement Review | Complete | SR0208-000 | ||||
Paliperidone palmitate | Reimbursement Review | Complete | SR0206-000 | ||||
Telmisartan / Amlodipine | Reimbursement Review | Cancelled | SR0207-000 | ||||
Sapropterin dihydrochloride | Reimbursement Review | Complete | SR0205-000 | ||||
Canakinumab | Reimbursement Review | Complete | SR0204-000 | ||||
Ticagrelor | Reimbursement Review | Cancelled | SR0203-000 | ||||
Dabigatran etexilate | Reimbursement Review | Cancelled | SR0202-000 | ||||
Tocilizumab | Reimbursement Review | Complete | SR0201-000 | ||||
Prasugrel hydrochloride | Reimbursement Review | Complete | SR0200-000 | ||||
Calcitriol | Reimbursement Review | Complete | SR0199-000 | ||||
Tadalafil | Reimbursement Review | Complete | SR0197-000 | ||||
Darunavir | Reimbursement Review | Complete | SR0194-000 | ||||
Portable Monitoring Devices for Diagnosis of Obstructive Sleep Apnea at Home: Review of Accuracy, Cost-Effectiveness, Guidelines, and Coverage in Canada | Health Technology Review | M0002-000 | |||||
Hydromorphone hydrochloride | Reimbursement Review | Complete | SR0190-000 | ||||
Raltegravir | Reimbursement Review | Complete | SR0191-000 | ||||
Loteprednol etabonate | Reimbursement Review | Complete | SR0186-000 |